Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Oncotargets and Therapy
|
November 25, 2020
Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated <i>NPM1</i> in a Patient with Clonal Hematopoiesis: A Case Report
Sotirios G Papageorgiou, Aspasia Divane, Maria Roumelioti, et al.
Nature Communications
|
June 11, 2024
Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
Athina Varveri, Miranta Papadopoulou, Zacharias Papadovasilakis, et al.
Journal of Clinical Medicine
|
August 12, 2023
Primary Adrenal Lymphomas with Cushing's Syndrome: Two Cases with Evidence of Endogeneous Cortisol Production by the Neoplastic Lymphoid Cells
Sotirios G Papageorgiou, Ioanna Mavroeidi, Marios Kostakis, et al.
Journal for Immunotherapy of Cancer
|
January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
Jianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Science Translational Medicine
|
April 13, 2018
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade
Natalie J Neubert, Martina Schmittnaegel, Natacha Bordry, et al.
The European Respiratory Journal
|
January 28, 2022
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
Konstantinos Evangelou, Dimitris Veroutis, Koralia Paschalaki, et al.
Oncoimmunology
|
September 18, 2018
Lymphatic vessel density is associated with CD8
Natacha Bordry, Maria A S Broggi, Kaat de Jonge, et al.
Clinical Immunology (Orlando, Fla.)
|
September 16, 2018
Safety profile after prolonged C3 inhibition
Edimara S Reis, Nadja Berger, Xin Wang, et al.
Cancer Research Communications
|
August 14, 2023
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
Myrto Moutafi, Georgia-Angeliki Koliou, George Papaxoinis, et al.
Cell Reports
|
July 21, 2021
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING
Marine Bruand, David Barras, Marco Mina, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Oncotargets and Therapy
|
November 25, 2020
Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated <i>NPM1</i> in a Patient with Clonal Hematopoiesis: A Case Report
Sotirios G Papageorgiou, Aspasia Divane, Maria Roumelioti, et al.
Nature Communications
|
June 11, 2024
Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
Athina Varveri, Miranta Papadopoulou, Zacharias Papadovasilakis, et al.
Journal of Clinical Medicine
|
August 12, 2023
Primary Adrenal Lymphomas with Cushing's Syndrome: Two Cases with Evidence of Endogeneous Cortisol Production by the Neoplastic Lymphoid Cells
Sotirios G Papageorgiou, Ioanna Mavroeidi, Marios Kostakis, et al.
Journal for Immunotherapy of Cancer
|
January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
Jianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Science Translational Medicine
|
April 13, 2018
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade
Natalie J Neubert, Martina Schmittnaegel, Natacha Bordry, et al.
The European Respiratory Journal
|
January 28, 2022
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
Konstantinos Evangelou, Dimitris Veroutis, Koralia Paschalaki, et al.
Oncoimmunology
|
September 18, 2018
Lymphatic vessel density is associated with CD8
Natacha Bordry, Maria A S Broggi, Kaat de Jonge, et al.
Clinical Immunology (Orlando, Fla.)
|
September 16, 2018
Safety profile after prolonged C3 inhibition
Edimara S Reis, Nadja Berger, Xin Wang, et al.
Cancer Research Communications
|
August 14, 2023
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
Myrto Moutafi, Georgia-Angeliki Koliou, George Papaxoinis, et al.
Cell Reports
|
July 21, 2021
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING
Marine Bruand, David Barras, Marco Mina, et al.
Page
of 7